Fibrobiologics

IN THE PRESS

Lone Star Bio

FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024

June 6, 2024

·

5 min read

Lone Star Bio

FibroBiologics Announces 2024 Annual Meeting of Stockholders

May 15, 2024

·

1 min read

Business

FibroBiologics Files 2024 First Quarter Report

May 14, 2024

·

1 min read

Lone Star Bio

FibroBiologics to Present at the BIO International Convention 2024

May 7, 2024

·

1 min read

Business

FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids

April 25, 2024

·

4 min read

Policy

FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office

April 11, 2024

·

4 min read

Lone Star Bio

FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA

April 4, 2024

·

5 min read

Lone Star Bio

FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment

March 19, 2024

·

4 min read

Lone Star Bio

FibroBiologics to Present at Advanced Wound Care Summit USA

March 13, 2024

·

4 min read

Business

FibroBiologics Appoints Ruben A. Garcia as General Counsel

March 6, 2024

·

4 min read

JOBS